Authors
Latest:
Study: Guillain-Barré Five Times More Likely in Unvaccinated COVID-19-Positive Patients Than Vaccinated PatientsPatients can sometimes develop Guillain-Barre syndrome after having a recent respiratory illness or digestive tract infection and, in rare cases, after receiving certain vaccines.
Latest:
Minnesota Fights Back Against Rising Insulin CostsAlec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.
Latest:
Help Optimize Care for Orphan, Rare Lung Diseases Amid COVID-19 PandemicThe value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.
Latest:
Drug Sequestration in the Management of Patients with Extracorporeal Membrane Oxygenation SupportDosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.
Latest:
Tips to Finding Balance: Being a Well-Rounded Student PharmacistFrom countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
Latest:
Clinical Overview: Empagliflozin for Type 2 Diabetes Patients With Cardiovascular Disease or Heart Failure, Reduced Ejection FractionEmpagliflozin has been found to lower the risk of death due to cardiovascular events and the number of first and recurrent heart failure hospitalizations.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
How Precision Dosing Technology Helps Prevent Adverse EventsPrecision dosing technology uses multiple patient-specific factors to individualize medication doses, helping clinicians reduce medication errors that lead to adverse events.
Latest:
The Role of Daridorexant in the Treatment of InsomniaAlthough pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.
Latest:
Nivolumab-AVD Poised to be New Standard of Care for Hodgkin Lymphoma in Both Adults, Pediatric PatientsThe phase 3 S1826 trial is the largest Hodgkin lymphoma study in NCTN history.
Latest:
Ousting the Pain: Migraine in University StudentsStudents may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.
Latest:
Shorter Course of Treatment for CAP in Children Demonstrates SuccessPediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
Latest:
How Does the EUA for the COVID-19 Vaccines Work?FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.
Latest:
Supporting Medication Adherence With Motivational InterviewingMotivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
Latest:
Pharmacy Schools Can Break Down Barriers Between Pharmacists, Deaf CommunityMost pharmacists and technicians are unaware of resources that aid in communication.
Latest:
Oncology Pharmacists Bring Value and Contribute to Cancer CareOncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
Latest:
The Challenges in Launching Alaska's First Pharmacy SchoolA shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.
Latest:
Regional Trends Reinforcing Breast Cancer Therapeutics MarketOver the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.
Latest:
How the White House's New FDA Commissioner Caused the Baby Formula CrisisThe FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.
Latest:
As Easy as ABE: A Pharmacist’s Overview of Updates to the COPD GOLD GuidelinesData show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.
Latest:
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral OncologyPAPs can significantly reduce OOP costs for patients.
Latest:
Current Drug Pathways in Non–Small Cell Lung CancerAdvancements in genomic and mutational analysis show that up to 60% of adenocarcinomas and up to 50% to 80% of squamous cell carcinomas (SCC) have a known oncogenic driver mutation.
Latest:
Dengue Vaccine: What Pharmacists Need to KnowThe FDA approved the first vaccine for dengue disease in May 2019.
Latest:
How Pharmacists Can Use Advanced Medication Decision Support to Improve Health, Curtail CostsAs pharmacists’ role in the health of communities continues to grow, it becomes even more critical for pharmacists to be armed with advanced technology when providing drug analysis.
Latest:
Multiple Myeloma Therapy Often Causes Cardiovascular ComplicationsMany patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Latest:
How to Create an Inclusive Culture for LGBTQ+ Patients at the Pharmacy: A Practical ApproachFacilitating environmental cues that members of the LGBTQ+ community look for to signify that they are in a safe space is an especially important element for the LGBTQ+ community.
Latest:
Clinical Overview: Dapagliflozin for Patients with Heart Failure, Reduced Ejection Fraction and Preserved Ejection FractionManagement of heart failure focuses on avoiding reversible precipitants and optimizing guideline-directed therapy to lower mortality and hospitalizations.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
